Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Cochran

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Immunology|December 1, 1986
Inhibition of lymphocyte motility by interleukin 2D S Hoon, D R Wen, M Stene, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materialsA J Cochran, G Todd, D M Hart, et al.
Progress in Clinical and Biological Research|January 1, 1988
Immunobiology of human cutaneous melanomaA J Cochran, D R Wen, M Stene, et al.
Annals of the New York Academy of Sciences|January 1, 1983
S-100 protein: a marker for melanocytic tumorsD R Wen, S Bhuta, H R Herschman, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1987
Bronchial anastomosis with a tissue adhesiveM Hachida, P Naruns, S Morris, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
International Journal of Cancer|November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneityS Kanda, A J Cochran, W R Lee, et al.
Melanoma Research|October 1, 1993
S-100 protein remains a practical marker for melanocytic and other tumoursA J Cochran, H F Lu, P X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2007
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tellR A Scolyer, R Murali, J E Gershenwald, et al.
British Journal of Cancer|February 1, 1975
Proceedings: Immunity in patients with breast cancerA J Cochran, R M Mackie, C E Ross, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Immunology|December 1, 1986
Inhibition of lymphocyte motility by interleukin 2D S Hoon, D R Wen, M Stene, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materialsA J Cochran, G Todd, D M Hart, et al.
Progress in Clinical and Biological Research|January 1, 1988
Immunobiology of human cutaneous melanomaA J Cochran, D R Wen, M Stene, et al.
Annals of the New York Academy of Sciences|January 1, 1983
S-100 protein: a marker for melanocytic tumorsD R Wen, S Bhuta, H R Herschman, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1987
Bronchial anastomosis with a tissue adhesiveM Hachida, P Naruns, S Morris, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
International Journal of Cancer|November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneityS Kanda, A J Cochran, W R Lee, et al.
Melanoma Research|October 1, 1993
S-100 protein remains a practical marker for melanocytic and other tumoursA J Cochran, H F Lu, P X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2007
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tellR A Scolyer, R Murali, J E Gershenwald, et al.
British Journal of Cancer|February 1, 1975
Proceedings: Immunity in patients with breast cancerA J Cochran, R M Mackie, C E Ross, et al.
Pageof 18